Just the Facts on BioPharmX Corporation (BPMX)

BioPharmX Corporation (BPMX) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $0.31, down from yesterday’s close by -7.12%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

BioPharmX Corporation (BPMX) currently trades with a market capitalization of $36.74 Million. That value represents a market adjusting for revenues that have been falling by -45.45 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$16.9 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$0.04 on a per share basis this quarter. Perhaps, that suggests something about why 10.10% of the outstanding share supply is held by institutional investors.

Technical Analysis

It’s important to check the technicals to get a sense of how BPMX has been acting. Looking at the stock’s movement on the chart, BioPharmX Corporation recorded a 52-week high of $0.90. It is now trading 0.59% off that level. The stock is trading $0.18 its 50-day moving average by -0.13%. The stock carved out a 52-week low down at $0.10.

In recent action, BioPharmX Corporation (BPMX) has made a move of +82.35% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 16.68, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 8.90% with $117.38 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of BPMX.

Previous articleThe Case for and Against RAIT Financial Trust (RAS)
Next articleTaking a Look at the Data Behind Rite Aid Corporation (RAD)